Literature DB >> 11845451

ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients.

M Alecu1, S Alecu, G Coman, E Gălăţescu, C Ursaciuc.   

Abstract

The levels of ICAM-1, ELAM-1, TNF-alpha and IL-6 were determined in 12 patients with pemphigus vulgaris (PV) both in serum and the blister liquid. As a control, the same parameters were determined in 7 patients with herpes zoster (HZ). The patients with PV presented significantly higher values of ICAM-1 in the blister liquid, as compared to the serum values. The values of TNF-alpha and IL-6 were increased both in serum and the blister liquid. The ELAM-1 values did not show significant differences between serum and the blister liquid. In HZ patients, the blister liquid values did not significantly exceed the serum values both for ICAM-1 and ELAM-1. TNF-alpha and IL-6 presented high values both in serum and the blister liquid. We consider that the high values of ICAM-1 in the blister liquid from PV patients suggest the involvement of this adhesion molecule in the PV pathogenic features. The implication of ICAM-1 could be nonspecific and limited, and could possibly represent a reaction to the destruction of the desmosomal bonds within keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11845451

Source DB:  PubMed          Journal:  Roum Arch Microbiol Immunol        ISSN: 1222-3891


  8 in total

1.  Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Ali Karaouni; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

2.  Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis.

Authors:  Alex M Rokni; Marissa Ayasse; Adnan Ahmed; Lauren Guggina; Robert W Kantor; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2022-03-09       Impact factor: 3.017

3.  Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.

Authors:  Steve Marchenko; Alexander I Chernyavsky; Juan Arredondo; Vivian Gindi; Sergei A Grando
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

4.  [Gold. Effective therapy for mucosal lesions of pemphigus vulgaris].

Authors:  D Lange; F Meiss; E Fiedler; K Treiber; W C Marsch; M Fischer
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

5.  Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients.

Authors:  Joanna Narbutt; Joanna Boncela; Katarzyna Smolarczyk; Cezary Kowalewski; Katarzyna Wozniak; Jolanta Dorota Torzecka; Anna Sysa-Jedrzejowska; Czesław S Cierniewski; Aleksandra Lesiak
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

6.  Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris.

Authors:  Joanna Narbutt; Jolanta Lukamowicz; Jarosław Bogaczewicz; Anna Sysa-Jedrzejowska; Jolanta Dorota Torzecka; Aleksandra Lesiak
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

7.  Identification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene.

Authors:  Dan Vodo; Ofer Sarig; Shamir Geller; Edna Ben-Asher; Tsviya Olender; Ron Bochner; Ilan Goldberg; Judith Nosgorodsky; Anna Alkelai; Pavel Tatarskyy; Alon Peled; Sharon Baum; Aviv Barzilai; Saleh M Ibrahim; Detlef Zillikens; Doron Lancet; Eli Sprecher
Journal:  PLoS Genet       Date:  2016-05-05       Impact factor: 5.917

8.  Analysis of Serum Cytokine Profile in Pemphigus.

Authors:  Sang Hee Lee; Won Jin Hong; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.